Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aconitine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112250632B details a green synthesis route for 3,14,15-triacetyl aconitine using DMAP catalysis, offering significant cost reduction and scalable purification for cardiac drug manufacturing.
Patent CN104098511A reveals a novel acetylation method converting N-deacetyllappaconitine byproducts into high-purity lappaconitine, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Advanced dual-solvent recrystallization method achieving >97% purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective purification.
Novel synthesis of lappaconitine acetal derivatives offers mild conditions and high safety for scalable antitumor pharmaceutical intermediates manufacturing supply chains.
Patent CN106632365B reveals a novel one-pot synthesis for high-purity lappaconitine-isatin hybrids, offering significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101503358A details a novel organocatalytic route using Lappaconitine for chiral intermediates, offering safer processing and reduced metal contamination risks.